Related Experiment Videos

The activation of Csk by CD4 interferes with TCR-mediated activatory signaling

Barbara Marinari1, Luca Simeoni, Burkhart Schraven

  • 1Department of Cellular and Developmental Biology, La Sapienza University, I-00185 Rome, Italy.

Insights

Antibodies targeting CD4 can inhibit T cell activation by inducing the p50(csk) inhibitory kinase. This blocks T cell receptor (TCR) signaling pathways, preventing IL-2 gene expression and T cell activation.

Area of Science:

  • Immunology
  • Cell Signaling

Background:

  • T cell activation relies on CD4-Lck recruitment to the T cell receptor (TCR)/CD3 complex.
  • Blocking CD4-Lck interaction inhibits T cell activation by disrupting early and late signaling phases.

Purpose of the Study:

  • To investigate a novel inhibitory mechanism by which CD4 can suppress proximal T cell-activating signals.
  • To elucidate the role of CD4 ligation by antibodies in regulating T cell signaling.

Main Methods:

  • Investigated the activation of the inhibitory kinase p50(csk) upon CD4 ligation by antibodies.
  • Assessed Csk kinase association with the membrane adapter PAG/Cbp.
  • Analyzed early tyrosine phosphorylation events and downstream signaling pathways, including IL-2 gene expression.

Main Results:

  • Antibody-mediated CD4 ligation strongly induced and prolonged p50(csk) activation.
  • p50(csk) was not activated when TCR and CD4 were properly engaged by their natural ligands.
  • Anti-CD4 treatment stimulated Csk kinase associated with PAG/Cbp, inhibiting TCR-induced phosphorylation and IL-2 expression.

Conclusions:

  • CD4, when ligated by antibodies, can activate the inhibitory kinase p50(csk), leading to suppression of T cell activation.
  • This study proposes a new model for CD4-mediated negative signaling in T cells.
  • Understanding this mechanism offers insights into regulating T cell responses.

Related Concept Videos